Repligen (RGEN) Reports In-Line Q3 EPS

Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $15.6 million.

Repligen sees FY2014 revenue of $60-62 million, versus prior guidance of $59-62 million and the consensus of $0.28 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

You May Also Be Interested In

• BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
• Darden Restaurants (DRI) Tops Q4 EPS by 3c, Misses on Revenue; Offers FY27 Guidance
• KKR reports over $900M in Q2 monetization income through June 24